These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11399324)
1. Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Cloutier SM; Couty S; Terskikh A; Marguerat L; Crivelli V; Pugnières M; Mani JC; Leisinger HJ; Mach JP; Deperthes D Mol Immunol; 2000 Dec; 37(17):1067-77. PubMed ID: 11399324 [TBL] [Abstract][Full Text] [Related]
2. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. Wang X; Campoli M; Ko E; Luo W; Ferrone S J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013 [TBL] [Abstract][Full Text] [Related]
4. The role of valency in the selection of anti-carbohydrate single-chain Fvs from phage display libraries. MacKenzie R; To R J Immunol Methods; 1998 Nov; 220(1-2):39-49. PubMed ID: 9839924 [TBL] [Abstract][Full Text] [Related]
5. Ligation-based assembly for constructing mouse synthetic scFv libraries by chain shuffling with in vivo-amplified VH and VL fragments. Nishi M; Jian N; Yamamoto K; Seto H; Nishida Y; Tonoyama Y; Shimizu N; Nishi Y J Immunol Methods; 2014 Oct; 412():53-69. PubMed ID: 25010461 [TBL] [Abstract][Full Text] [Related]
6. Development of Listeria monocytogenes-specific immunomagnetic beads using a single-chain antibody fragment. Paoli GC; Kleina LG; Brewster JD Foodborne Pathog Dis; 2007; 4(1):74-83. PubMed ID: 17378711 [TBL] [Abstract][Full Text] [Related]
7. Generation of a panel of related human scFv antibodies with high affinities for human CEA. Osbourn JK; Field A; Wilton J; Derbyshire E; Earnshaw JC; Jones PT; Allen D; McCafferty J Immunotechnology; 1996 Sep; 2(3):181-96. PubMed ID: 9373311 [TBL] [Abstract][Full Text] [Related]
9. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Kipriyanov SM; Little M; Kropshofer H; Breitling F; Gotter S; Dübel S Protein Eng; 1996 Feb; 9(2):203-11. PubMed ID: 9005442 [TBL] [Abstract][Full Text] [Related]
10. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy. Winthrop MD; DeNardo SJ; Albrecht H; Mirick GR; Kroger LA; Lamborn KR; Venclovas C; Colvin ME; Burke PA; DeNardo GL Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182 [TBL] [Abstract][Full Text] [Related]
11. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. Schier R; Bye J; Apell G; McCall A; Adams GP; Malmqvist M; Weiner LM; Marks JD J Mol Biol; 1996 Jan; 255(1):28-43. PubMed ID: 8568873 [TBL] [Abstract][Full Text] [Related]
12. Preparation of single chain variable fragment of MG(7) mAb by phage display technology. Yu ZC; Ding J; Nie YZ; Fan DM; Zhang XY World J Gastroenterol; 2001 Aug; 7(4):510-4. PubMed ID: 11819819 [TBL] [Abstract][Full Text] [Related]
13. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics. DeNardo SJ; DeNardo GL; DeNardo DG; Xiong CY; Shi XB; Winthrop MD; Kroger LA; Carter P Clin Cancer Res; 1999 Oct; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366 [TBL] [Abstract][Full Text] [Related]
14. A simple vector system to improve performance and utilisation of recombinant antibodies. Martin CD; Rojas G; Mitchell JN; Vincent KJ; Wu J; McCafferty J; Schofield DJ BMC Biotechnol; 2006 Dec; 6():46. PubMed ID: 17156422 [TBL] [Abstract][Full Text] [Related]
15. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library. Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083 [TBL] [Abstract][Full Text] [Related]
16. Phage versus phagemid libraries for generation of human monoclonal antibodies. O'Connell D; Becerril B; Roy-Burman A; Daws M; Marks JD J Mol Biol; 2002 Aug; 321(1):49-56. PubMed ID: 12139932 [TBL] [Abstract][Full Text] [Related]
17. Isolation of scFv antibody fragments against HER2 and CEA tumor antigens from combinatorial antibody libraries derived from cancer patients. Ayat H; Burrone OR; Sadghizadeh M; Jahanzad E; Rastgou N; Moghadasi S; Arbabi M Biologicals; 2013 Nov; 41(6):345-54. PubMed ID: 23845693 [TBL] [Abstract][Full Text] [Related]
18. A simple and robust approach to immobilization of antibody fragments. Ikonomova SP; He Z; Karlsson AJ J Immunol Methods; 2016 Aug; 435():7-16. PubMed ID: 27142477 [TBL] [Abstract][Full Text] [Related]
19. One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector. Zhao Q; Chan YW; Lee SS; Cheung WT Protein Expr Purif; 2009 Dec; 68(2):190-5. PubMed ID: 19683057 [TBL] [Abstract][Full Text] [Related]
20. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation. Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]